Advertisement
Screener

DYNAVOX INC. Forms 3, 4 and 5: Stock Options

DYNAVOX INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows, 13 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2013-05-24: Reporting owner Merk Raymond J.; Form 3; Security Stock Options (right to buy); Transaction Holding.
  • 2013-05-24: Reporting owner Merk Raymond J.; Form 3; Security Stock Options (right to buy); Transaction Holding.
  • 2012-06-13: Reporting owner Heying Michelle L.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2012-06-13: Reporting owner Misch Kenneth D; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2013-05-24
holding as of filing
Merk Raymond J.
Officer (CFO & Corporate Secretary)
3Stock Options (right to buy)
Derivative · Direct
Holding$15.00
exercise price
2013-05-24
2013-05-24
holding as of filing
Merk Raymond J.
Officer (CFO & Corporate Secretary)
3Stock Options (right to buy)
Derivative · Direct
Holding$5.47
exercise price
2013-05-24
2012-06-13Heying Michelle L.
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+150,000
150,000 owned after
$1.21
exercise price
2012-06-14
2012-06-13Misch Kenneth D
Officer (Chief Financial Officer)
4Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$1.21
exercise price
2012-06-14
2011-09-14Heying Michelle L.
Director, Officer (President and CEO)
4Stock Options (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+27,400
27,400 owned after
$5.47
exercise price
2012-06-14
2011-09-14Misch Kenneth D
Officer (Chief Financial Officer)
4Stock Options (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,300
18,300 owned after
$5.47
exercise price
2011-09-15
2011-09-14Cunningham Robert E
Officer (Chief of Clinical Pathways)
4Stock Options (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,100
9,100 owned after
$5.47
exercise price
2011-09-15
2011-09-14Heying Michelle L.
Officer (President and COO)
4Stock Options (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+27,400
27,400 owned after
$5.47
exercise price
2011-09-15
2010-04-22
holding as of filing
SMOREY-GIGER MARCY
Officer (Chief Legal Officer)
3Stock Options (right to buy)
Derivative · Direct
Holding$15.00
exercise price
2010-04-22
2010-04-22
holding as of filing
Cunningham Robert E
Officer (Chief Technology Officer)
3Stock Options (right to buy)
Derivative · Direct
Holding$15.00
exercise price
2010-04-22
2010-04-22
holding as of filing
Misch Kenneth D
Officer (Chief Financial Officer)
3Stock Options (right to buy)
Derivative · Direct
Holding$15.00
exercise price
2010-04-22
2010-04-22
holding as of filing
Heying Michelle L.
Officer (President and COO)
3Stock Options (right to buy)
Derivative · Direct
Holding$15.00
exercise price
2010-04-22
2010-04-22
holding as of filing
Donnelly Edward L Jr
Director, Officer (Chief Executive Officer)
3Stock Options (right to buy)
Derivative · Indirect · By Edward Donnelly Jr. Trust
Holding$15.00
exercise price
2010-04-22